Recent Global Data report reveals that more migraine cases are prevalent in seven major countries at a rate of 0.13% emphasizes the importance of early diagnosis and prevention of migraine.
The 12-month total prevalent cases of migraine in the seven major markets are expected to increase from 72.7 million cases in 2020 to 73.7 million cases in 2030, at an annual growth rate (AGR) of 0.13%, according to Global Data, a leading data and analytics company. This latest report reveals that in 2030, the US will have the highest number of 12-month total prevalent cases of migraine in the 7MM at 42.6 million cases, whereas Spain will have the lowest number of cases with nearly 3.9 million.
‘The US will have the highest number of migraine prevalent cases, whereas Spain will have the lowest number of cases by 2030.’
Adults up to those aged 50 accounted for more than 72% of the 12-month total prevalent cases of migraine in the 7MM, while those aged 70 years and older accounted for less than 10%.Migraine is consistently described in studies to be more common in women compared to men. In the 7MM, the 12-month total prevalent cases of episodic migraine were predominantly based on frequency. In terms of type, migraine without aura was the most common type for migraine in the 7MM.
Antara Bhattacharya, MPH, Senior Epidemiologist at GlobalData, comments: “A higher burden of migraine in the productive age groups and disabling symptoms both substantially increase the economic burden of migraine. Despite this, the disease remains highly undiagnosed and undertreated. Therefore, more country-specific epidemiological studies are needed to elucidate the prevalence proportions in the adult population”.
Early diagnosis and symptomatic and preventive treatments can only reduce the severity of attacks as there is no permanent cure. For early diagnosis and disease prevention, better knowledge of the etiology of migraine is required.
Advertisement